Altering Lipids for Tolerance of Aromatase Inhibitor Therapy
NCT04268134
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
77
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Interventions
DIETARY_SUPPLEMENT:
Omega-3 fatty acid supplement
Sponsor
University of Michigan Rogel Cancer Center